Please login to the form below

Genesis Research Group

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company also supports pharmaceutical and biotech clients with tech-enabled, dedicated partnerships delivered via a unique engagement model that enables life sciences companies to better address complex needs.

Areas of Expertise


  • HEOR & Real-World Evidence Strategy
  • Value Proposition Development & Testing
  • Advisory Boards & Payer Panels
  • Scientific Advice
  • HTA / ICER Support
  • Market Access Strategy
  • Pricing & Reimbursement


  • Claims & EHR Database Analyses
  • Chart Reviews & Patient Registries
  • Meta-Analyses & Indirect Treatment Comparisons
  • Targeted & Systematic Literature Reviews
  • Modeling & Simulations
  • RWE Studies / Data Services
  • Data Analytics & Biostatistics


  • EVID AI: Artificial Intelligence & Machine Learning
  • Technology-Assisted Literature Reviews
  • Interactive Data Dashboards
  • Evidence Management Platforms
  • Data Portals
  • RWE Automation


  • Evidence Slide Decks for MSL & Commercial Teams
  • Interactions with, and submissions, to HTA & Regulatory Authorities
  • Value Dossiers
  • Objection Handlers
  • Scientific Journal Manuscripts
  • Conference Presentations
  • Communications Planning


Frank A. Corvino
Chief Executive Officer
View LinkedIn profile
Joseph DiCesare
President & Chief Strategy Officer
View LinkedIn profile
Chris Pashos
Chief Medical Officer & Head of Research Partnerships
View LinkedIn profile
Stephen Ralston
Executive Vice President and Head of EU Business Development
View LinkedIn profile

Press Releases

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access' at 11am ET, 20 October

Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining Genesis Research, Ms. Fillman was Senior Vice President and CFO Clinical Solutions at Syneos Health.

Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators
Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.
Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).

Genesis Research Acquires Market Access Transformation

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”), a leading provider of technology-enabled payer research platforms.

GHO Capital Acquires Genesis Research

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services.

Genesis Research: What is EVID AI?

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches

Videos and Podcasts


“We are really impressed with the efficiency and quality of the work, your leadership skills, and the extra efforts you’ve made to ensure the results are absolutely accurate.”

HEOR / RWE client, 2021